Related Experiment Video
Updated: Jun 14, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Interplay between MDM2, MDMX, Pirh2 and COP1: the negative regulators of p53
Lan Wang1, Guifen He, Pingzhao Zhang
1State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai, 200433, People's Republic of China.
Abstract:
MDM2, Pirh2 and COP1 are important E3 ubiquitin ligases, which directly interact with p53 and target p53 for proteasome-mediated degradation. MDMX, the MDM2 homologous protein, inhibits p53-mediated transcription activity. The interplay between MDM2, MDMX, Pirh2 and COP1 has not been reported, except the interaction between MDM2 and MDMX. Here, we reported that there were interactions between these four proteins independently of p53. The protein levels of MDM2, MDMX, Pirh2 and COP1 changed when any two of them were co-transfected. Our data also showed that the integrity of MDM2 RING finger domain was crucial for its ability to elevate the protein levels of COP1 and Pirh2. Any two of these four proteins could inhibit p53-mediated transcriptional activity synergistically. Furthermore, COP1 inhibited MDM2 self-ubiquitination and interfered with MDMX ubiquitination by MDM2. Our results suggest that MDM2, MDMX, Pirh2 and COP1 might inhibit p53 activity synergistically in vivo.
Insights
MDM2, Pirh2, COP1, and MDMX E3 ligases interact and regulate each other, independently of p53. These proteins synergistically inhibit p53 activity and alter their own protein levels.
Area of Science:
- Molecular Biology
- Cellular Biology
- Biochemistry
Background:
- MDM2, Pirh2, and COP1 are E3 ubiquitin ligases targeting p53 for degradation.
- MDMX inhibits p53 transcriptional activity.
- Interactions among MDM2, MDMX, Pirh2, and COP1 were previously unreported, except for MDM2-MDMX.
Purpose of the Study:
- To investigate the interactions between MDM2, MDMX, Pirh2, and COP1.
- To elucidate the functional consequences of these interactions on p53.
- To explore the synergistic effects of these proteins on p53 regulation.
Main Methods:
- Co-transfection experiments to assess protein interactions and levels.
- Analysis of MDM2 RING finger domain integrity.
- Assessment of p53-mediated transcriptional activity.
- Ubiquitination assays for MDM2 and MDMX.
Main Results:
- MDM2, MDMX, Pirh2, and COP1 interact independently of p53.
- Co-transfection of any two proteins altered their individual protein levels.
- MDM2 RING finger domain integrity is essential for elevating COP1 and Pirh2 levels.
- These four proteins synergistically inhibit p53 transcriptional activity.
- COP1 inhibits MDM2 self-ubiquitination and MDMX ubiquitination by MDM2.
Conclusions:
- MDM2, MDMX, Pirh2, and COP1 form a complex that regulates p53.
- These proteins likely collaborate to inhibit p53 activity in vivo.
- The findings reveal a novel regulatory network impacting p53 stability and function.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Positive Regulator Molecules
Positive Regulator Molecules
Master Transcription Regulators

